RSS   Newsletter   Contact   Advertise with us
Post Online Media

Aldeyra appoints Richard H. Douglas to board

AldeyraAldeyra Therapeutics, a biotechnology company, announced the appointment of Richard H. Douglas to the board of directors of the company.

Dr. Douglas is the former Senior Vice President, Corporate Development, Genzyme Corporation.

From 1989 to 2011, the year Genzyme was acquired by Sanofi (now Sanofi Genzyme), Dr. Douglas led Genzyme Corporation's Corporate Development team, and was involved in numerous acquisitions, licenses, financings, joint ventures, and strategic alliances.

Prior to his work at Genzyme Corporation, Dr. Douglas served in science and corporate development capacities at Integrated Genetics.

Dr. Douglas holds a B.S. in chemistry from the University of Michigan, a Ph.D. in biochemistry from the University of California, Berkeley and was a postdoctoral fellow in Leroy Hood's laboratory at the California Institute of Technology.

Dr. Douglas currently serves on the University of Michigan Technology Transfer National Advisory Board and as a member of the Board of Directors of Novavax, Inc.


 LATEST MOVES FROM Massachusetts 


 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy